McDaid; Ronan
Patent Applications and Registrations
Patent applications and USPTO patent grants for McDaid; Ronan.The latest application filed is for "anti-cd3 antibodies and uses thereof".
- McDaid; Ronan - Spring House PA
- MCDAID; Ronan - Eagleville PA
| Patent | Date |
|---|---|
| Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof Grant 10,844,122 - Anderson , et al. November 24, 2 | 2020-11-24 |
| Anti-cd3 Antibodies And Uses Thereof App 20200048349 - GAUDET; Francois ; et al. | 2020-02-13 |
| Anti-cd33 Antibodies, Anti-cd33/anti-cd3 Bispecific Antibodies And Uses Thereof App 20190382481 - Diem; Michael ; et al. | 2019-12-19 |
| CD123 binding agents and uses thereof Grant 9,850,310 - Gaudet , et al. December 26, 2 | 2017-12-26 |
| Anti-ror1, Antibodies, Ror1 X Cd3 Bispecific Antibodies, And Methods Of Using The Same App 20170210799 - ANDERSON; Glenn Mark ; et al. | 2017-07-27 |
| Prostate Specific Membrane Antigen (PSMA) Bispecific Binding Agents and Uses Thereof App 20160347840 - Anderson; Glenn ; et al. | 2016-12-01 |
| CD123 Binding Agents and Uses Thereof App 20160068605 - Nemeth; Jennifer F. ; et al. | 2016-03-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 